Today’s announcement builds on a previous announcement of more than 40% off the Eliquis list price, a direct-to-consumer ...

The expiration of ACA tax credits threatens $32 billion in healthcare revenue, risking coverage for millions and increasing ...

MedImpact launches a performance-driven PMPM pricing model, enhancing cost predictability and accountability for health plans amid rising pharmacy expenses.

The FDA letter requested that a technical information update be included in the Chemistry Manufacturing and Controls (CMC) ...

Panelists discuss how bimekizumab demonstrated significant improvements in pain scores (from baseline levels around 60/100) and fatigue measures, with meaningful percentages of patients achieving ...

Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster ...

Increasing the cholesterol-lowering protein ApoM in mice improved retinal health and may be the key to slowing age-related ...

Tremfya is now the first and only fully subcutaneous IL-23 inhibitor approved to treat both ulcerative colitis and Crohn’s ...

Yael Bensoussan, M.D., director of the University of South Florida Health Voice Center, discusses menopause-related voice ...

Carbapenemase-producing Enterobacterales (CRE) surge in the U.S., with New Delhi metallo-β-lactamase (NDM) becoming a major public health threat.

Research shows older adults had 4.45 million skin cancer cases in 2021. Basal cell carcinoma is expected to double by 2050 worldwide.

The Advisory Committee on Immunization Practices pulled back its recommendation concerning a shot that combines the measles, ...